The kinin system:: suggestions to broaden some prevailing concepts

被引:12
作者
Erdös, EG
Deddish, PA
机构
[1] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612 USA
[3] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA
关键词
kinin system; ACE; bradykinin;
D O I
10.1016/S1567-5769(02)00166-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The existence and importance of the kallikrein-kinin-kininase system, especially in the circulation, has taken over three-quarters of a century to be established. Finding the multiple components derived from renin-angiotensin and their functions stretched over a century [Erdos EG. Perspectives on the early history of angiotensin-converting enzyme-recent follow-ups. In: Giles TD, editor. Angiotensin-converting enzyme (ACE): clinical and experimental insights. Fort Lee: Health Care Communications; 2001, p. 3-16]. Although the discoveries were made independently, it was shown in 1970 that the angiotensin I-converting enzyme (ACE) is identical with kininase II, previously discovered by us, thus, a single protein can regulate either the activation or inactivation of the two peptide products. It followed that inhibitors of ACE can affect both processes [Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80]. After being engaged for a long time in characterizing the metabolism of various bio-active peptides, we, as well as others, noticed that the effect of ACE inhibitors go beyond simply blocking angiotensin (Ang) II release and bradykinin (BK) inactivation by the enzyme [Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 2002; 109(2):195 - 209, Yamada K, Erdos EG. Kallikrein and prekallikrein of the isolated basolateral membrane of rat kidney. Kidney Int 1982;22:331-7]. It also became apparent to us that in the complex multistep reactions needed to activate the kallikrein-kinin system, there should be some shortcuts-shunts-to accelerate and simplify important processes. Thus, some basic tenets developed after decades of intensive laboratory investigations-and by now generally accepted-can be challenged. For example, it should be considered that the activities of BK and Lys BK (kallidin) can be substantially different, and that sequentially linked reactions, starting with prokallikrein activation and leading to kinin release from kininogen and inhibition of kininases, may be only one way to activate kinin receptors. A summary of some suggested alterations on prevailing concepts is given below. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:1741 / 1746
页数:6
相关论文
共 30 条
[1]   ACE INHIBITORS ARE ENDOTHELIUM DEPENDENT VASODILATORS OF CORONARY-ARTERIES DURING SUBMAXIMAL STIMULATION WITH BRADYKININ [J].
AUCHSCHWELK, W ;
BOSSALLER, C ;
CLAUS, M ;
GRAF, K ;
GRAFE, M ;
FLECK, E .
CARDIOVASCULAR RESEARCH, 1993, 27 (02) :312-317
[2]  
Berne RM, 1972, CARDIOVASCULAR PHYSL, V2
[3]  
BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945
[4]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[5]   Neprilysin inhibitors potentiate effects of bradykinin on B2 receptor [J].
Deddish, PA ;
Marcic, BM ;
Tan, FL ;
Jackman, HL ;
Chen, ZL ;
Erdös, EG .
HYPERTENSION, 2002, 39 (02) :619-623
[6]   Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation [J].
Dendorfer, A ;
Reissmann, S ;
Wolfrum, S ;
Raasch, W ;
Dominiak, P .
HYPERTENSION, 2001, 38 (01) :142-146
[7]  
DIXON M, 1964, ENZYMES, P69
[8]   [PHE8-PSI(CH2-NH)ARG9]BRADYKININ, A B2-RECEPTOR SELECTIVE AGONIST WHICH IS NOT BROKEN DOWN BY EITHER KININASE-I OR KININASE-II [J].
DRAPEAU, G ;
RHALEB, NE ;
DION, S ;
JUKIC, D ;
REGOLI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) :193-195
[9]   Potentiation of bradykinin actions by ACE inhibitors [J].
Erdös, EG ;
Deddish, PA ;
Marcic, BM .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (06) :223-229
[10]   Kinins, the long march -: A personal view [J].
Erdös, EG .
CARDIOVASCULAR RESEARCH, 2002, 54 (03) :485-491